Kenji Shimizu

11.1k citations

221 papers · 8.9k indexed · 2 hit papers · h-index 48

Molecular Biology top 1%
Oncology top 0.5%
Immunology top 1%
Cancer Research top 1%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Mitchell Goldfarb Michael Wigler Mamoru Ouchida Elizabeth J. Taparowsky Manuel Perucho Takumi Maruhashi Taku Okazaki Il‐mi Okazaki
Topics: RNA modifications and cancer (38 papers)Cancer-related gene regulation (28 papers)Immune Cell Function and Interaction (21 papers)
Cited by: Oncology Cancer Research Immunology
Journals: Nature Science Cell
Partner nations: Japan United States China

In The Last Decade

Kenji Shimizu

211 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change

1982 596 citations Kenji Shimizu et al. profile →
Structure and activation of the human N-ras gene

1983 460 citations Kenji Shimizu et al. profile →

Peers

Countries citing papers authored by Kenji Shimizu

Since Specialization

Citations

This map shows the geographic impact of Kenji Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Shimizu more than expected).

Fields of papers citing papers by Kenji Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Shimizu. The network helps show where Kenji Shimizu may publish in the future.

Co-authorship network of co-authors of Kenji Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Shimizu. A scholar is included among the top collaborators of Kenji Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Shimizu. Kenji Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of 5’ untranslated region variants in genes involved in neurodevelopmental disorders 2026 ·Journal of Human Genetics ·(unknown),(unknown),(unknown),Kenji Shimizu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	0
2	Efficacy and safety of intravenous fosphenytoin for patients with acute herpes zoster‐associated pain: A placebo‐controlled randomized trial 2023 ·The Journal of Dermatology ·Masako Iseki,Takenobu Yamamoto,Youichi Ogawa,(unknown),Yoichiro Abe,Daisuke Watanabe,Fumimasa Amaya,Toshio Hasegawa,(unknown),(unknown),Yukiko Nomura,(unknown),Toshihisa Hamada,Kenji Shimizu,(unknown),(unknown),(unknown),(unknown),Makoto Kawashima	2
3	Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity 2022 ·Immunity ·Takumi Maruhashi,Daisuke Sugiura,Il‐mi Okazaki,Kenji Shimizu,(unknown),(unknown),Harunori Yoshikawa,Katsumi Maenaka,Naozumi Ishimaru,Hidetaka Kosako,Tatsuya Takemoto,Taku Okazaki	129
4	PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity 2022 ·Nature Immunology ·Daisuke Sugiura,Il‐mi Okazaki,(unknown),Takumi Maruhashi,Kenji Shimizu,Rieko Arakaki,Tatsuya Takemoto,Naozumi Ishimaru,Taku Okazaki	57
5	Robotic data acquisition with deep learning enables cell image–based prediction of transcriptomic phenotypes 2022 ·Proceedings of the National Academy of Sciences ·Jianshi Jin,Taisaku Ogawa,(unknown),Kirill Kryukov,Kenji Shimizu,Tomokatsu Ikawa,Tadashi Imanishi,Taku Okazaki,Katsuyuki Shiroguchi	14
6	TARM1 contributes to development of arthritis by activating dendritic cells through recognition of collagens 2021 ·Nature Communications ·Rikio Yabe,Soo-Hyun Chung,Masanori A. Murayama,Sachiko Kubo,Kenji Shimizu,(unknown),Takumi Maruhashi,Akimasa Seno,Tomonori Kaifu,Shinobu Saijo,Yoichiro Iwakura	18
7	PD-1 preferentially inhibits the activation of low-affinity T cells 2021 ·Proceedings of the National Academy of Sciences ·Kenji Shimizu,Daisuke Sugiura,Il‐mi Okazaki,Takumi Maruhashi,Tatsuya Takemoto,Taku Okazaki	14
8	Establishment of Novel High-Standard Chemiluminescent Assay for NTPase in Two Protozoans and Its High-Throughput Screening 2020 ·Marine Drugs ·(unknown),Jun Nagai,Riho Kurata,Kenji Shimizu,Xiaofeng Cui,Takayuki Isagawa,Hiroaki Semba,Jun Ishihara,Yasuhiro Yoshida,Norihiko Takeda,Koji Maemura,(unknown)	4
9	Restriction of PD-1 function by cis -PD-L1/CD80 interactions is required for optimal T cell responses 2019 ·Science ·Daisuke Sugiura,Takumi Maruhashi,Il‐mi Okazaki,Kenji Shimizu,(unknown),Tatsuya Takemoto,Taku Okazaki	285
10	Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota 2018 ·Nature Immunology ·Ce Tang,Shigeru Kakuta,Kenji Shimizu,Motohiko Kadoki,Tomonori Kamiya,Tomoyuki Shimazu,Sachiko Kubo,Shinobu Saijo,Harumichi Ishigame,Susumu Nakae,Yoichiro Iwakura	132
11	LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII 2018 ·Nature Immunology ·Takumi Maruhashi,Il‐mi Okazaki,Daisuke Sugiura,(unknown),(unknown),Kenji Shimizu,Taku Okazaki	202
12	Human RAD 17 Polymorphism at Codon 546 Is Associated with the Risk of Colorectal Cancer. 2017 ·PubMed ·Yukiko Yasuda,Akiko Sakai,Sachio Ito,Kaori Sasai,Hiromasa Yamamoto,Nagahide Matsubara,Mamoru Ouchida,Hiroshi Katayama,Kenji Shimizu	3
13	Liposomal Delivery of MicroRNA-7–Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells 2011 ·Molecular Cancer Therapeutics ·Kammei Rai,Nagio Takigawa,Sachio Ito,(unknown),Eiki Ichihara,Tatsuji Yasuda,Kenji Shimizu,Mitsune Tanimoto,Katsuyuki Kiura	110
14	Multi-Step Aberrant CpG Island Hyper-Methylation Is Associated with the Progression of Adult T–Cell Leukemia/Lymphoma 2009 ·American Journal Of Pathology ·(unknown),Takashi Oka,(unknown),(unknown),Kana Washio,Masayuki Takano,Katsuyoshi Takata,Toshiaki Morito,(unknown),Maiko Tamura,Yuta Kitamura,Nobuya Ohara,Mamoru Ouchida,Koichi Ohshima,Kenji Shimizu,Mitsune Tanimoto,Kiyoshi Takahashi,Masao Matsuoka,Atae Utsunomiya,Tadashi Yoshino	58
15	MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors 2008 ·International Journal of Cancer ·Takafumi Kubo,Hiromasa Yamamoto,William W. Lockwood,(unknown),Junichi Soh,Michael Peyton,Masaru Jida,Hiroki Otani,Tetsuya Fujii,Mamoru Ouchida,Nagio Takigawa,Katsuyuki Kiura,Kenji Shimizu,Hiroshi Date,John D. Minna,Marileila Varella‐Garcia,Wan L. Lam,Adi F. Gazdar,Shinichi Toyooka	117
16	A Case of Laparotomy in Adult Henoch-Schoenlein Purpura with Chief Complaint of Abdominal Symptoms 2004 ·The Japanese Journal of Gastroenterological Surgery ·Kenji Shimizu,Akihito Nakanishi,Takashi Hayashi,(unknown),(unknown)	0
17	Anomalous pancreaticobiliary ductal junction without bile duct dilatation in gallbladder cancer. 2001 ·PubMed ·Ayman Elnemr,Tomohiko Ohta,(unknown),(unknown),(unknown),Tohru Tani,Kenji Shimizu,G Nishimura,Tetsuya Terada,K Miwa	22
18	TR-IA4号機特集 Transient Crystal Growth Rate in Microgravity:Report from TR-IA-4 Rocket Experiment 1998 ·K. Tsukamoto,(unknown),(unknown),(unknown),Kenji Shimizu,(unknown),Shinichi Yoda	0
19	Inhibition of growth of some enteropathogenic strains in mixed cultures of Streptococcus faecalis and Clostridium butyricum 1989 ·(unknown),Kenji Shimizu,Masanori Sasatsu,(unknown)	9
20	Isolation and Preliminary Characterization of the Chinese Hamster Thymidine Kinase Gene 1983 ·Molecular and Cellular Biology ·John A. Lewis,Kenji Shimizu,David Zipser	38

About Kenji Shimizu

Kenji Shimizu is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 221 papers that have together received 8.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (38 papers), Cancer-related gene regulation (28 papers) and Immune Cell Function and Interaction (21 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (1.3k citations) and Immunology (1.6k citations). Kenji Shimizu has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Mitchell Goldfarb, Michael Wigler, Mamoru Ouchida, Elizabeth J. Taparowsky, Manuel Perucho, Takumi Maruhashi, Taku Okazaki, Il‐mi Okazaki, Daisuke Sugiura and Ottavio Fasano. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact